Search
GSK's £400m Cambridge Global Centre of Excellence: What the Investment Means for UK Life Sciences and Regulatory Affairs Careers
GSK's £400 million Cambridge investment will fund a new flagship research and development centre on the Cambridge Biomedical Campus, housing more than 1,000 scientists and replacing GSK's long-standing Stevenage site by 2029. Announced on 28 July 2026, the move forms part of a wider £1.9 billion cost-savings programme and is framed by the UK government as evidence that its Modern Industrial Strategy is attracting investment into life sciences. For regulatory affairs professio
Jul 3112 min read
Twenty Years in Big Pharma — And Still Couldn't Get Into Regulatory Affairs Without Training
Part of the Entry to Regulatory Success Stories Series Forhad had spent over two decades inside three of the most respected organisations in pharmaceutical science — GSK, Charles River Laboratories, and AstraZeneca. He was a Senior Scientist. He had a biochemistry degree and a Master's in Pharmaceutical Sciences. He understood drug molecules from hit identification all the way through to clinical candidate. And when he decided he wanted to move into regulatory affairs, the in
Jun 1914 min read